|
Showing the most relevant articles for your search:NASDAQ:AVXS | Date | Time | Source | Headline | Symbol | Company | | 02/20/2018 | 8:00AM | GlobeNewswire Inc. | AveXis to Report Fourth Quarter and Full Year 2017 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/14/2018 | 6:24PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/14/2018 | 5:51PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/13/2018 | 1:44PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/13/2018 | 9:38AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/05/2018 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/05/2018 | 5:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/05/2018 | 5:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/30/2018 | 5:03PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/30/2018 | 4:01PM | GlobeNewswire Inc. | AveXis to Initiate Screening for Remaining Patients in Pivotal Trial of AVXS-101 for SMA Type 1 Following Review of Prelimina... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/29/2018 | 4:58PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/22/2018 | 4:05PM | GlobeNewswire Inc. | AveXis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additiona... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/18/2018 | 5:12PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/18/2018 | 4:46PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/18/2018 | 4:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/16/2018 | 8:18PM | GlobeNewswire Inc. | AveXis Announces Pricing of Public Offering of Common Stock | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/16/2018 | 7:40AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/16/2018 | 7:30AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/16/2018 | 7:25AM | GlobeNewswire Inc. | AveXis Announces Proposed Public Offering of Common Stock | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/16/2018 | 7:20AM | GlobeNewswire Inc. | AveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/09/2018 | 8:02AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/08/2018 | 8:00AM | GlobeNewswire Inc. | REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commerciali... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/08/2018 | 8:00AM | GlobeNewswire Inc. | REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commerciali... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/04/2018 | 5:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/04/2018 | 5:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/04/2018 | 5:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/04/2018 | 4:19PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 01/04/2018 | 4:00PM | GlobeNewswire Inc. | AveXis Announces Alignment with FDA on Next Steps Toward a BLA Submission for AVXS-101 in SMA Type 1 | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 12/13/2017 | 4:09PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 12/13/2017 | 4:00PM | GlobeNewswire Inc. | AveXis Announces Plan to Initiate Phase 1 Trial in SMA Type 2 Utilizing Intrathecal Delivery of AVXS-101 | NASDAQ:AVXS | Avexis, Inc. (delisted) |
|
Showing the most relevant articles for your search:NASDAQ:AVXS |
|